Literature DB >> 9364660

Insulinoma: a review of current management.

R D Bliss1, P B Carter, T W Lennard.   

Abstract

Insulinomas are a relatively rare tumour which occur predominantly in the pancreas. The majority of the tumours are benign, but have profound effects upon the patient. The diagnosis of insulinoma is often elusive, and the management may involve demanding surgery with a significant morbidity. In this review article, all clinical aspects of insulinomas are examined. Particular emphasis is placed on the myriad modes of presentation, and the methods used to localise the tumour pre-operatively. Medical, as well as surgical treatments are discussed and their role in the management of both malignant and benign tumours. Despite potential difficulties encountered in managing patients with this tumour, a large majority may be either cured or achieve useful palliation.

Entities:  

Mesh:

Year:  1997        PMID: 9364660     DOI: 10.1016/s0960-7404(97)00004-2

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  3 in total

1.  Diagnostic difficulties in long-standing insulinoma with near-normal plasma insulin levels.

Authors:  L Czupryniak; J Strzelczyk; J Drzewoski
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

2.  Insulinoma.

Authors:  Andrew R Burns; Alan P B Dackiw
Journal:  Curr Treat Options Oncol       Date:  2003-08

3.  Insulinoma presenting as medically intractable temporal lobe epilepsy.

Authors:  So-Hee Park; Dong Wook Kim
Journal:  J Epilepsy Res       Date:  2014-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.